Long-term fracture risk in patients with Crohn's disease: A population-based study in Olmsted County, Minnesota

Gastroenterology

Volumn 123, Issue 2, 2002, Pages 468-475

  Loftus Jr , Edward V ^a   Crowson, Cynthia S ^a   Sandborn, William J ^a   Tremaine, William J ^a   O'Fallon, William M ^a   Melton, L Joseph ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; COHORT ANALYSIS; CROHN DISEASE; FEMALE; FRACTURE; HIGH RISK POPULATION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SURGICAL APPROACH; UNITED STATES;

EID: 0036322962     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.34779     Document Type: Article

References (60)

1. Review article: Osteoporosis, corticosteroids and inflammatory bowel disease
2. Osteoporosis as a risk in inflammatory bowel disease
3. Bones and Crohn's: Problems and solutions
4. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease
5. Reduced bone density in patients with inflammatory bowel disease
6. Bone mineral density in children and young adults with Crohn's disease
7. Osteopenia and osteoporosis in Crohn's disease: Prevalence in a Dutch population-based cohort
8. A controlled study of bone mineral density in patients with inflammatory bowel disease
9. Detection of osteoporosis in patients with inflammatory bowel disease
10. Low bone mineral density in patients with inflammatory bowel disease
11. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease
12. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis
13. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study
14. Inflammatory bowel disease and predisposition to osteopenia
15. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study
16. Evolution of osteopenia in inflammatory bowel disease
17. Osteoporosis and determinants of bone density in patients with Crohn's disease
18. Bone mineral density assessment in children with inflammatory bowel disease
19. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease
20. Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography
21. Biochemical markers and bone densitometry in inflammatory bowel disease
22. Osteoporosis in patients with inflammatory bowel disease - Prevalence and risk factors
23. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: Cross-sectional data from a population-based study
24. Risk factors for low bone mineral density in children and young adults with Crohn's disease
25. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease
26. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn's disease
27. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis
28. Bone loss in patients with inflammatory bowel disease: A prospective study
29. Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections
30. Genetic factors determine extent of bone loss in inflammatory bowel disease
31. Allelic variation at the interleukin 1 beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases
32. Osteoporosis in patients with inflammatory bowel disease
33. Bone mineral density in patients with inflammatory bowel disease
34. Altered bone metabolism in inflammatory bowel disease
35. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: A case-control cross-sectional study of 113 patients
36. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
37. Vertebral compression fractures in pediatric patients with Crohn's disease
38. Screening for low bone mass in Crohn's disease: Incidence of osteopenia and osteoporosis in 500 unselected cases
39. Osteoporotic vertebral fractures in patients with Crohn's disease
40. Predictors of hip fractures in elderly men
41. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
42. The incidence of fracture among patients with inflammatory bowel disease - A population-based cohort study
43. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease
44. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: A systematic review
45. History of the Rochester Epidemiology Project
46. The patient record in epidemiology
47. Epidemiologic aspects of Crohn's disease: A population based study in Olmsted County, Minnesota, 1943-1982
48. Crohn's disease in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival
49. The threat to medical-records research
50. Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985-1989
51. Epidemiology of fractures
52. Regression models and life-tables
53. Downturn in hip fracture incidence
54. Long-term trends in the incidence of distal forearm fractures
55. Epidemiologic features of humeral fractures
56. Fracture incidence in Olmsted County, Minnesota: Comparison of urban with rural rates and changes in urban rates over time
57. Some simple approximate tests for Poisson variates
58. Non-parametric estimation from incomplete observations
59. Prevalence and incidence of vertebral deformities